Skip to main content

Beraprost








Beraprost


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search

































Beraprost
Structure of Beraprost.png
Clinical data

AHFS/Drugs.com
International Drug Names
Routes of
administration		Oral
ATC code

  • B01AC19 (WHO)

Pharmacokinetic data
Bioavailability50–70%
MetabolismUnknown
Elimination half-life
35–40 minutes
Identifiers
CAS Number

  • 88430-50-6 ☑Y88475-69-8

PubChem CID
  • 6917951
IUPHAR/BPS
  • 1967
ChemSpider

  • 5293169 ☑Y
UNII
  • 35E3NJJ4O6
ChEMBL

  • ChEMBL1207745 ☒N
Chemical and physical data
Formula
C24H30O5
Molar mass398.492 g/mol
3D model (JSmol)
  • Interactive image

.mw-parser-output .noboldfont-weight:normal
 ☒N☑Y (what is this?)
  (verify)

Beraprost is a pharmaceutical drug used in several Asian countries, including Japan and South Korea, as a vasodilator and antiplatelet agent.[1] It is classified as a prostacyclin analog.[1][2]


It has been studied for the treatment of pulmonary hypertension and for use in avoiding reperfusion injury.



Clinical pharmacology[edit]


As an analog of prostacyclin PGI2, beraprost affects vasodilation, which in turn lowers blood pressure. Beraprost also inhibits platelet aggregation, though the role this phenomenon may play in relation to pulmonary hypertension has yet to be determined.



Dosage and administration[edit]


Beraprost is administered orally as a pill available in strength of 20 mcg. Dose ranges from 60 to 180 mcg in divided doses after meals.



References[edit]




  1. ^ ab "Beraprost". drugs.com..mw-parser-output cite.citationfont-style:inherit.mw-parser-output qquotes:"""""""'""'".mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em


  2. ^ Melian EB, Goa KL (2002). "Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension". Drugs. 62 (1): 107–33. doi:10.2165/00003495-200262010-00005.
















Retrieved from "https://en.wikipedia.org/w/index.php?title=Beraprost&oldid=822000410"





Navigation menu

























(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.740","walltime":"0.919","ppvisitednodes":"value":5624,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":246763,"limit":2097152,"templateargumentsize":"value":7765,"limit":2097152,"expansiondepth":"value":16,"limit":40,"expensivefunctioncount":"value":2,"limit":500,"unstrip-depth":"value":1,"limit":20,"unstrip-size":"value":6048,"limit":5000000,"entityaccesscount":"value":2,"limit":400,"timingprofile":["100.00% 682.286 1 -total"," 63.19% 431.151 1 Template:Drugbox"," 44.11% 300.963 1 Template:Infobox"," 28.62% 195.276 16 Template:Navbox"," 18.13% 123.731 1 Template:Reflist"," 14.41% 98.307 16 Template:Unbulleted_list"," 11.88% 81.073 1 Template:Cite_web"," 10.21% 69.649 1 Template:Prostanoidergics"," 6.22% 42.458 1 Template:Infobox_drug/chemical_formula"," 5.94% 40.513 21 Template:Abbr"],"scribunto":"limitreport-timeusage":"value":"0.229","limit":"10.000","limitreport-memusage":"value":4720335,"limit":52428800,"cachereport":"origin":"mw1293","timestamp":"20181215073543","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":125,"wgHostname":"mw1263"););
-

Popular posts from this blog

The Dalles, Oregon

Image
The Dalles, Oregon From Wikipedia, the free encyclopedia Jump to navigation Jump to search This article is about the city in Oregon. For the nearby geological formation, see Celilo Falls. For other uses, see Dalles. Not to be confused with the town of Dallas, Oregon. City in Wasco County The Dalles City The Dalles and the Columbia River in November 2008 Flag Seal Motto(s):  "Cognito timor Vincit" (Latin), "Knowledge Conquers Fear" (English) Location in Oregon Coordinates: 45°36′4″N 121°10′58″W  /  45.60111°N 121.18278°W  / 45.60111; -121.18278 Coordinates: 45°36′4″N 121°10′58″W  /  45.60111°N 121.18278°W  / 45.60111; -121.18278 County Wasco County Incorporated 1857 Government  • Mayor Stephen Elliott Lawrence (D) [1] [2] Area [3]  • Total 6.61 sq mi (17.12...
Read more

眉山市

Image
Clash Royale CLAN TAG #URR8PPP   关于同名地方，参见：眉山郡、眉山县、眉山专区、眉山地区。 body.skin-minerva .mw-parser-output table.infobox captiontext-align:center 眉山市 三苏祠 简称 眉 地名出处 1.以峨眉山为名、2.城郊有山，分左右两峰，远望如眉，眉山由此而得名，此山现位于眉山电信“6501”单位内部、3.源于苏东坡。据说有人见他眉如山丘，智冠五...
Read more

清晰法令

Image
Clash Royale CLAN TAG #URR8PPP 本條目 部分链接不符合格式手冊規範 。跨語言链接及章節標題等處的链接可能需要清理。 ( 2015年12月11日 ) 請協助改善此條目。參見WP:LINKSTYLE、WP:MOSIW以了解細節。突出显示跨语言链接可以便于检查。 維基百科的法律內容只供參考， 並不能視作專業意見 。任何法律問題應諮詢相關司法管轄權...
Read more